Novel study on reducing alcohol consumption
Design by Veronika Stratiewski
Thank you for your interest in our study on the effect of a single dose of ketamine in combination with neurofeedback training to support alcohol reduction (compensation up to CHF 550). The Nektar study, led by PD Dr. med. Marcus Herdener and PD Dr. Katrin Preller at the Psychiatric University Hospital Zurich, is investigating a novel, neuroscientifically based treatment approach with the aim of optimizing the therapy of people with alcohol use disorder (AUD).
On this website you will also find further information about Goal and Procedure of the Study
Those interested are welcome to register via the Contact form or contact us with any further questions.